Non-disruptive TP53 mutations, which cause partial loss of p53 function having a retained functional property associated with gain of function (GOF) representing a heterogenous subgroup of ALK rearranged NSCLC patients with inferior PFS [47]. Here, ALK is linked to non-small cell lung carcinoma.